<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>After the oral administration of the COX 2 inhibitor <z:chebi fb="0" ids="8887">rofecoxib</z:chebi> (<z:chebi fb="0" ids="8887">Vioxx</z:chebi>) as part of an oral provocation test, a 64-year-old woman developed <z:hpo ids='HP_0011009'>acute</z:hpo> anterograde and <z:e sem="disease" ids="C0002624" disease_type="Mental or Behavioral Dysfunction" abbrv="">retrograde amnesia</z:e> which lasted for several hours </plain></SENT>
<SENT sid="1" pm="."><plain>The patient did not show symptoms of <z:mp ids='MP_0002531'>anaphylaxis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Neurological examination did not reveal focal symptoms or an <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizure</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Diffusion-weighted magnetic resonance imaging only showed a small region of increased signal intensity in the left hippocampus </plain></SENT>
<SENT sid="4" pm="."><plain>The patient thus had no anaphylactic drug reaction, but a <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> (<z:mp ids='MP_0004110'>TGA</z:mp>) or amnestic episode </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0004110'>TGA</z:mp> is an <z:hpo ids='HP_0011009'>acute</z:hpo>, reversible, cerebral dysfunctional state which lasts from 1 h up to maximally 24 h and which is associated with anterograde and <z:e sem="disease" ids="C0002624" disease_type="Mental or Behavioral Dysfunction" abbrv="">retrograde amnesia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>While about half of the cases appear to occur spontaneously, other cases are preceded by physically or emotionally stressful events </plain></SENT>
<SENT sid="7" pm="."><plain>In our patient it may have been the <z:e sem="disease" ids="C0700361" disease_type="Mental or Behavioral Dysfunction" abbrv="">emotional distress</z:e> caused by the oral provocation testing that has triggered the <z:mp ids='MP_0004110'>TGA</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>When <z:mp ids='MP_0004110'>TGA</z:mp> occurs during oral challenge of drugs, we recommend repeating the oral challenge of the tested drug </plain></SENT>
</text></document>